Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | FAAH | O00519 | 4/20 | 0.70 |
| ▸ | DGKA | P23743 | 1/20 | 0.65 |
| ▸ | PGR | P06401 | 2/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.62 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 1/20 | 0.61 |
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7557819 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL6853542 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL119944 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL588561 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| Ethyl Oleate SCHEMBL2798 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL3847096 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL25490302 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL588560 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| Ethyl Oleate SCHEMBL1896892 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR | |
| SCHEMBL12842074 | 1.00 | HSD17B10 (0.73) | HSD17B10CYP3A4ALOX15ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| WO-2025090952-A1 | DESATURASE VARIANTS AND METHODS OF USE | GENOMATICA, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| EP-4493683-A1 | ACYL-ACP THIOESTERASE VARIANTS AND USES THEREOF | Genomatica, Inc. (US) | 2025-01-22 | — | — | EP | claimed |
| CN-117924997-A | Special printing ink capable of printing embroidery or water drop effect on paper surface | 厦门创业人环保科技股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2024018436-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC (HU) | 2024-01-25 | — | — | WO | claimed |
| WO-2023178193-A1 | ACYL-ACP THIOESTERASE VARIANTS AND USES THEREOF | GENOMATICA, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| CN-116199885-A | Reactive organopolysiloxane, process for producing the same, modified powder, and base cosmetic containing the modified powder | 湖南斯洛柯有机硅有限公司 | 2023-06-02 | — | — | CN | claimed |
| EP-3360575-B1 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS | BESINS HEALTHCARE LU SARL (LU) | 2023-04-19 | — | — | EP | claimed |
| US-20230060937-A1 | SIMULTANEOUS GENE EDITING AND HAPLOID INDUCTION | SYNGENTA PARTICIPATIONS AG (CH) | 2023-03-02 | — | — | US | claimed |
| EP-2493508-A2 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS | Besins Healthcare Luxembourg SARL (LU) | 2012-09-05 | — | — | EP | claimed |
| US-8258330-B1 | Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil | Naturalis, S.A. (CL) | 2012-09-04 | — | — | US | claimed |
| US-8110670-B2 | Enhanced production of fatty acid derivatives | LS9, INC. (US) | 2012-02-07 | — | — | US | claimed |
| WO-2011051354-A2 | TRANSDERMAL PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENTS | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2011-05-05 | — | — | WO | claimed |
| US-20110098258-A1 | Transdermal Pharmaceutical Compositions Comprising Active Agents | BESINS HEALTHCARE LUXEMBOURG | 2011-04-28 | — | — | US | claimed |
| US-20100251601-A1 | ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES | LS9, INC. (US) | 2010-10-07 | — | — | US | claimed |
| EP-2129785-A2 | ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES | Ls9, Inc. (US) | 2009-12-09 | — | — | EP | claimed |
| WO-2008119082-A2 | ENHANCED PRODUCTION OF FATTY ACID DERIVATIVES | LS9, INC. (US) | 2008-10-02 | — | — | WO | claimed |
| CN-1751601-A | Low cholesterol eggs rich in conjugate linoleic acid, and its prodn. method | NO 1 OCEANOLOGY RES INST OF ST (CN) | 2006-03-29 | — | — | CN | claimed |
| US-4820513-A | LINALOOL AND UPWARD FLIGHT STIMULANT | UNIVERSITY OF SOUTHAMPTON (GB) | 1989-04-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | HSD17B10 1085/4885CYP3A4 1977/4885ALOX15 3494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.